Cláudia Martins

ORCID: 0000-0001-5417-6974
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Nanoparticle-Based Drug Delivery
  • Advanced Drug Delivery Systems
  • Nanoplatforms for cancer theranostics
  • biodegradable polymer synthesis and properties
  • Extracellular vesicles in disease
  • Glioma Diagnosis and Treatment
  • Barrier Structure and Function Studies
  • Innovative Microfluidic and Catalytic Techniques Innovation
  • Graphene and Nanomaterials Applications
  • Electrospun Nanofibers in Biomedical Applications
  • RNA Interference and Gene Delivery
  • MicroRNA in disease regulation
  • Bone Tissue Engineering Materials
  • Cancer Research and Treatments
  • Advanced biosensing and bioanalysis techniques
  • Glycosylation and Glycoproteins Research
  • Drug Solubulity and Delivery Systems
  • Microfluidic and Capillary Electrophoresis Applications
  • Edible Oils Quality and Analysis
  • Immune cells in cancer
  • Dye analysis and toxicity
  • Catalysis for Biomass Conversion
  • Fermentation and Sensory Analysis
  • Free Radicals and Antioxidants
  • Tea Polyphenols and Effects

i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto
2017-2025

Polytechnic Institute of Bragança
2024-2025

Universidade do Porto
2015-2024

University of Nottingham
2019-2020

Cooperativa de Ensino Superior Politécnico e Universitário
2018-2019

Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da Saúde
2018-2019

Centro Hospitalar Tondela-Viseu
2015-2018

Abstract Fully simulating the components and microstructures of soft tissue is a challenge for its functional regeneration. A new aligned hydrogel microfiber scaffold spinal cord regeneration constructed with photocrosslinked gelatin methacryloyl (GelMA) electrospinning technology. The directional porous fibrous consistent nerve axons vital to guide cell migration axon extension. GelMA electrospun fibers soak up water more than six times their weight, lower Young's modulus, providing...

10.1002/adfm.201806899 article EN Advanced Functional Materials 2018-12-02

Abstract Minimal therapeutic advances have been achieved over the past two decades for glioblastoma (GBM), which remains an unmet clinical need. Here, hypothesis‐driven stimuli‐responsive nanoparticles (NPs) docetaxel (DTX) delivery to GBM are reported, with multifunctional features that circumvent insufficient blood‐brain barrier (BBB) trafficking and lack of targeting—two major hurdles anti‐GBM therapies. NPs dual‐surface tailored a i) brain‐targeted acid‐responsive Angiopep‐2 moiety...

10.1002/smll.202300029 article EN cc-by-nc-nd Small 2023-02-28

The competitive adsorption of phenolic acids, secoiridoids, and flavonoids in a molecularly imprinted polymer (MIP) functionalized with 4-vinylpiridine (4VP) moieties is analyzed here considering vanillic acid, oleuropein, quercetin as reference molecules. Measured isotherms highlight much stronger binding capacity the quercetin-MIP particles toward compared acid oleuropein. acquired data were used to design scale-up sorption/desorption processes aiming at fractionation olive leaf extracts....

10.1021/acs.jced.3c00543 article EN cc-by Journal of Chemical & Engineering Data 2024-02-28

Despite research efforts to discover new drugs for Parkinson treatment, the majority of candidates fail in preclinical and clinical trials due inadequate pharmacokinetic properties, namely blood-brain barrier permeability. Within high demand introduce market, nanotechnology can be used as a solution. Accordingly, PEGylated PLGA nanoparticles (NPs) were smart delivery carrier solve suboptimal aqueous solubility, which precludes its use vivo assays, potent, reversible, selective monoamine...

10.1021/acsami.8b17224 article EN ACS Applied Materials & Interfaces 2018-10-23

The separation of different types bioactive compounds in olive leaf is demonstrated with a tailored adsorbent functionalized pyridyl moieties and sorption–desorption processes developed to use only hydroalcoholic solvents. competitive binding isotherms mixtures vanillic acid, oleuropein, quercetin, maslinic, oleanolic acids water/ethanol solvents, the composition ranging from 50/50 up 100% ethanol, prove feasibility such classes molecules. two industrial extracts crude compositions were...

10.1021/acs.iecr.4c04622 article EN cc-by Industrial & Engineering Chemistry Research 2025-02-26

Background: Actually, no drugs provide therapeutic benefit to approximately one-third of depressed patients. Depression is predicted become the first global disease by 2030. So, new interventions are imperative.Research design and methods: Venlafaxine-loaded poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) were surface functionalized with two ligands against transferrin receptor enhance access brain. An in vitro blood–brain barrier model using hCMEC/D3 cell line was developed...

10.1080/17425247.2019.1690452 article EN Expert Opinion on Drug Delivery 2019-11-07

Demyelinating disorders, with a particular focus on multiple sclerosis (MS), have multitude of detrimental cognitive and physical effects the patients. Current treatment options that involve substances promoting remyelination fail in clinics due to difficulties reaching central nervous system (CNS). Here, dual encapsulation retinoic acid (RA) into lipid nanocapsules nominal size 70 nm, low PdI 0.1, coupled super paramagnetic iron oxide nanoparticles (SPIONs) was accomplished, joined by an...

10.1016/j.jconrel.2023.04.034 article EN cc-by Journal of Controlled Release 2023-04-28

The uptake and transport of dietary antioxidants remains the most important setback for their application in therapy. To overcome limitations, a PEGylated-based platform was developed to improve delivery properties two hydroxycinnamic (HCA) antioxidants-caffeic ferulic acids. antioxidant new polymer-antioxidant conjugates (PEGAntiOxs), prepared by linking poly(ethylene glycol) (PEG) cinnamic acids one-step Knovenagel condensation reaction, were evaluated. PEGAntiOxs present higher...

10.1021/acs.bioconjchem.8b00151 article EN Bioconjugate Chemistry 2018-04-11

Biochemical and biophysical cues governing glioblastoma (GBM) progression are complex dynamic. Tumor blood vessels, often recognized only by their transport functions, more deeply involved in this process. Vessels tumor immune evasion, matrix alterations stem cell stimulation, contributing for treatment resistance patients’ poor survival. Given vessel dynamic nature, they hardly represented conventional GBM monolayered vitro models. However, other approaches, such as three-dimensional (3D)...

10.3389/fddev.2022.823412 article EN cc-by Frontiers in Drug Delivery 2022-02-17

Abstract Inflammatory Bowel Disease (IBD) is a chronic inflammatory condition affecting the gastrointestinal tract (GIT). Glucagon‐like peptide‐2 (GLP‐2) analogs possess high potential in treatment of IBD by enhancing intestinal repair and attenuating inflammation. Due to enzymatic degradation poor absorption, GLP‐2 are administered parenterally, which leads patient compliance. This work aims develop IBD‐targeted nanoparticles (NPs) for oral delivery analog, Teduglutide (TED). Leveraging...

10.1002/smll.202402502 article EN Small 2024-07-15

Glioblastoma (GBM) is the deadliest adult brain cancer. The current standard-of-care chemotherapy using orally administered temozolomide (TMZ) presents poor improvement in patient survival, emphasizing compelling need for new therapies. A possible chemotherapeutic alternative docetaxel (DTX), which possesses higher tumoricidal potency against GBM cells. However, its limited blood-brain barrier (BBB) permeability poses a constraint on application. Nonetheless, nanomedicine offers promising...

10.1007/s13346-024-01659-x article EN cc-by Drug Delivery and Translational Research 2024-07-15

Despite being the most prevalent and lethal type of adult brain cancer, glioblastoma (GBM) remains intractable. Promising anti-GBM nanoparticle (NP) systems have been developed to improve anti-cancer performance difficult-to-deliver therapeutics, with particular emphasis on tumor targeting strategies. However, current disease modeling toolboxes lack close-to-native in vitro models that emulate GBM microenvironment bioarchitecture, thus partially hindering translation due poorly predicted...

10.1016/j.jconrel.2022.11.024 article EN cc-by-nc-nd Journal of Controlled Release 2022-11-24
Coming Soon ...